Glutamine synthetase mRNA releases sRNA from its 3´UTR to regulate carbon/nitrogen metabolic balance in Enterobacteriaceae

  1. Masatoshi Miyakoshi  Is a corresponding author
  2. Teppei Morita
  3. Asaki Kobayashi
  4. Anna Berger
  5. Hiroki Takahashi
  6. Yasuhiro Gotoh
  7. Tetsuya Hayashi
  8. Kan Tanaka
  1. University of Tsukuba, Japan
  2. Keio University, Japan
  3. Chiba University, Japan
  4. Kyushu University, Japan
  5. Tokyo Institute of Technology, Japan

Abstract

Glutamine synthetase (GS) is the key enzyme of nitrogen assimilation induced under nitrogen limiting conditions. The carbon skeleton of glutamate and glutamine, 2-oxoglutarate, is supplied from the TCA cycle, but how this metabolic flow is controlled in response to nitrogen availability remains unknown. We show that the expression of the E1o component of 2-oxoglutarate dehydrogenase, SucA, is repressed under nitrogen limitation in Salmonella enterica and E coli. The repression is exerted at the post-transcriptional level by an Hfq-dependent sRNA GlnZ generated from the 3´UTR of the GS-encoding glnA mRNA. Enterobacterial GlnZ variants contain a conserved seed sequence and primarily regulate sucA through base-pairing far upstream of the translation initiation region. During growth on glutamine as the nitrogen source, the glnA 3´UTR deletion mutants expressed SucA at higher levels than the S. enterica and E. coli wild-type strains, respectively. In E. coli, the transcriptional regulator Nac also participates in the repression of sucA. Lastly, this study clarifies that the release of GlnZ from the glnA mRNA by RNase E is essential for the post-transcriptional regulation of sucA. Thus the mRNA coordinates the two independent functions to balance the supply and demand of the fundamental metabolites.

Data availability

The RNA-seq data have been deposited in DDBJ DRA under accession number DRA012682.

The following data sets were generated

Article and author information

Author details

  1. Masatoshi Miyakoshi

    Department of Infection Biology, University of Tsukuba, Tsukuba, Japan
    For correspondence
    mmiyakoshi@md.tsukuba.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4901-2809
  2. Teppei Morita

    Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. Asaki Kobayashi

    Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  4. Anna Berger

    International Joint Degree Master's Program in Agro-Biomedical Science in Food and Health, University of Tsukuba, Tsukuba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Hiroki Takahashi

    Medical Mycology Research Center, Chiba University, Chiba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Yasuhiro Gotoh

    Department of Bacteriology, Kyushu University, Fukuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Tetsuya Hayashi

    Department of Bacteriology, Kyushu University, Fukuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6366-7177
  8. Kan Tanaka

    Laboratory for Chemistry and Life Science, Tokyo Institute of Technology, Yokohama, Japan
    Competing interests
    The authors declare that no competing interests exist.

Funding

Japan Society for the Promotion of Science (JP19H03464)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP19KK0406)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP21K19063)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP22H02236)

  • Kan Tanaka

Japan Society for the Promotion of Science (JP16H06279)

  • Hiroki Takahashi
  • Tetsuya Hayashi

Waksman Foundation of Japan

  • Masatoshi Miyakoshi

Takeda Medical Research Foundation

  • Masatoshi Miyakoshi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Alexander J. Westermann, Helmholtz Centre for Infection Research, Germany

Version history

  1. Preprint posted: July 25, 2022 (view preprint)
  2. Received: August 3, 2022
  3. Accepted: November 27, 2022
  4. Accepted Manuscript published: November 28, 2022 (version 1)
  5. Accepted Manuscript updated: November 29, 2022 (version 2)
  6. Version of Record published: December 8, 2022 (version 3)

Copyright

© 2022, Miyakoshi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,364
    views
  • 188
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Masatoshi Miyakoshi
  2. Teppei Morita
  3. Asaki Kobayashi
  4. Anna Berger
  5. Hiroki Takahashi
  6. Yasuhiro Gotoh
  7. Tetsuya Hayashi
  8. Kan Tanaka
(2022)
Glutamine synthetase mRNA releases sRNA from its 3´UTR to regulate carbon/nitrogen metabolic balance in Enterobacteriaceae
eLife 11:e82411.
https://doi.org/10.7554/eLife.82411

Share this article

https://doi.org/10.7554/eLife.82411

Further reading

    1. Microbiology and Infectious Disease
    Moagi Tube Shaku, Peter K Um ... Bavesh D Kana
    Research Article

    Mechanisms by which Mycobacterium tuberculosis (Mtb) evades pathogen recognition receptor activation during infection may offer insights for the development of improved tuberculosis (TB) vaccines. Whilst Mtb elicits NOD-2 activation through host recognition of its peptidoglycan-derived muramyl dipeptide (MDP), it masks the endogenous NOD-1 ligand through amidation of glutamate at the second position in peptidoglycan side-chains. As the current BCG vaccine is derived from pathogenic mycobacteria, a similar situation prevails. To alleviate this masking ability and to potentially improve efficacy of the BCG vaccine, we used CRISPRi to inhibit expression of the essential enzyme pair, MurT-GatD, implicated in amidation of peptidoglycan side-chains. We demonstrate that depletion of these enzymes results in reduced growth, cell wall defects, increased susceptibility to antibiotics, altered spatial localization of new peptidoglycan and increased NOD-1 expression in macrophages. In cell culture experiments, training of a human monocyte cell line with this recombinant BCG yielded improved control of Mtb growth. In the murine model of TB infection, we demonstrate that depletion of MurT-GatD in BCG, which is expected to unmask the D-glutamate diaminopimelate (iE-DAP) NOD-1 ligand, yields superior prevention of TB disease compared to the standard BCG vaccine. In vitro and in vivo experiments in this study demonstrate the feasibility of gene regulation platforms such as CRISPRi to alter antigen presentation in BCG in a bespoke manner that tunes immunity towards more effective protection against TB disease.

    1. Microbiology and Infectious Disease
    Ryan Thiermann, Michael Sandler ... Suckjoon Jun
    Tools and Resources

    Despite much progress, image processing remains a significant bottleneck for high-throughput analysis of microscopy data. One popular platform for single-cell time-lapse imaging is the mother machine, which enables long-term tracking of microbial cells under precisely controlled growth conditions. While several mother machine image analysis pipelines have been developed in the past several years, adoption by a non-expert audience remains a challenge. To fill this gap, we implemented our own software, MM3, as a plugin for the multidimensional image viewer napari. napari-MM3 is a complete and modular image analysis pipeline for mother machine data, which takes advantage of the high-level interactivity of napari. Here, we give an overview of napari-MM3 and test it against several well-designed and widely used image analysis pipelines, including BACMMAN and DeLTA. Researchers often analyze mother machine data with custom scripts using varied image analysis methods, but a quantitative comparison of the output of different pipelines has been lacking. To this end, we show that key single-cell physiological parameter correlations and distributions are robust to the choice of analysis method. However, we also find that small changes in thresholding parameters can systematically alter parameters extracted from single-cell imaging experiments. Moreover, we explicitly show that in deep learning-based segmentation, ‘what you put is what you get’ (WYPIWYG) – that is, pixel-level variation in training data for cell segmentation can propagate to the model output and bias spatial and temporal measurements. Finally, while the primary purpose of this work is to introduce the image analysis software that we have developed over the last decade in our lab, we also provide information for those who want to implement mother machine-based high-throughput imaging and analysis methods in their research.